March 13, 2025 · Form 4 insider transaction
ALTSHULER DAVID sold 3,231 shares of Vertex Pharmaceuticals Incorporated at $510.00 per share, a transaction worth $1.65M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1, which was entered into on 8/8/2024.